Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia

Infection and Immunity

Volumn 67, Issue 7, 1999, Pages 3488-3493

  Hill, Molly R ^a,c,f   Clarke, Stephen ^e   Rodgers, Kerry ^c   Thornhill, Brandi ^c   Peters, Jeffrey M ^d   Gonzalez, Frank J ^d   Gimble, Jeffrey M ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c OKLAHOMA CHRISTIAN UNIVERSITY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f QUHSC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENOFIBRATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIRINIXIC ACID;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CYTOKINE PRODUCTION; DRUG EFFECT; ENDOTOXEMIA; IMMUNOREGULATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION; SEPTIC SHOCK;

EID: 0033007231     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.7.3488-3493.1999     Document Type: Article

References (40)

1. Akira, S., T. Hirano, T. Taga, and T. Kishimoto. 1990. Biology of multifunctional cytokines: IL-6 and related molecules (IL 1 and TNF). FASEB J 4:2860-2867.
2. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12:141-179.
3. Blok, W. L., M. B. Katan, and J. van der Meer. 1996. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J. Nutr. 126: 1515-1533.
4. Bojes, H. K., D. R. Germolec, P. Simeonova, A. Bruccoleri, R. Schoonhoven, M. I. Luster, and R. G. Thurman. 1997. Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, Wy-14,643. Carcinogenesis 18:669-674.
5. Chengyu, J., A. T. Ting, and B. Seed. 1998. PPAR gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86.
6. Chinetti, G., S. Griglio, M. Antonucci, I. P. Torra, P. Delerive, Z. Majd, J.-C. Fruchart, J. Chapman, J. Najib, and B. Staels. 1998. Activation of proliferator-activated receptors alpha and gamma induces apoptosis in human monocyte-derived macrophages. J. Biol. Chem. 273:25573-25580.
7. Devchand, P., H. Keller, J. Peters, M. Vazquez, F. Gonzalez, and W. Wahli. 1996. The PPAR alpha-leukotriene B4 pathway to inflammation control. Nature 384:39-43.
8. DeWet, J. R., K. V. Wood, M. DeLuca, D. R. Helinski, and S. Subramani. 1987. Firefly luciferase gene: structure and expression in mammalian cells Mol. Cell. Biol. 7:725-737.
9. Dreyer, C., G. Krey, H. Keller, F. Givel, G. Helftenbein, and W. Wahli. 1992 Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68:879-887.
10. Feingold, K., J. Funk, A. Moser, J. Shigenaga, J. Rapp, and C. Grunfeld. 1995. Role for circulating lipoproteins in protection from endotoxin toxicity. Infect. Immun. 63:2041-2046.
11. Gimble, J. M., C. E. Robinson, X. Wu, K. A. Kelly, B. R. Rodriguez, S. A. Kliewer, J. M. Lehmann, and D. C. Morris. 1996. Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol. Pharmacol. 50:1087-1094.
12. Green, S. 1995. PPAR: a mediator of peroxisome proliferator action. Mutat. Res. 333:101-109.
13. Hertz, R., J. Bishara-Shieban, and J. Bar-Tana. 1995. Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III. J. Biol. Chem. 270:13470-13475.
14. Hill, M., K. Kelly, X. Wu, F. Wanker, H. Bass, C. Morgan, C.-S. Wang, and J. Gimble. 1995. Lipopolysaccharide regulation of lipoprotein lipase expresssion in murine macrophages. Infect. Immun. 63:858-864.
15. Hill, M., and R. McCallum. 1992. Identification of tumor necrosis factor as a transcriptional regulator of the phosphoenolpyruvate carboxykinase gene following endotoxin treatment of mice. Infect. Immun. 60:4040-4050.
16. Hill, M. R., M. D. Young, C. M. McCurdy, and J. M. Gimble. 1997. Decreased expression of murine PPARγ in adipose tissue during endotoxemia. Endocrinology 138:3073-3076.
17. Hill, M. R., R. D. Stith, and R. E. McCallum. 1986. Interleukin-1: a regulatory role in glucocorticoid-regulated hepatic metabolism. J. Immunol. 137: 858-862.
18. Kliewer, S., J. M. Lenhard, T. M. Willson, I. Patel, D. C. Morris, and J. M. Lehmann. 1995. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83:813-819.
19. Lee, S.S.-T., T. Pineau, J. Drago, E. Lee, J. Owens, D. Kroetz, P. Fernadez-Salguero, A. H. Westphal, and F. J. Gonzalez. 1995. Targeted disruption of the α isoform of the peroxisome proliferator-actiated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators Mol. Cell. Biol. 15:3012-3022.
20. Lehmann, J., L. Moore, T. Smith-Oliver, W. Wilkison, and S. K. T. Willson. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR-gamma). J. Biol. Chem. 270:12953-12956.
21. Lemberger, T., R. Saladin, M. Vazquez, F. Assimacopoulos, B. Staels, B. Desvergne, W. Wahli, and J. Auwerx. 1996. Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm. J. Biol. Chem. 271:1764-1769.
22. Mangelsdorf, D. J., U. Borgmeyer, R. A. Heyman, J. Y. Zhou, E. S. Ong, A. E. Oro, A. Kakizuka, and R. M. Evans. 1992. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev. 6:329-344.
23. Muerhoff, A. S., K. J. Griffen, and E. F. Johnson. 1992. The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid ω-hydroxylase, by clofibric acid. J. Biol. Chem. 267: 19051-19053.
24. Peters, J. M., R. C. Cattley, and F. J. Gonzalez. 1997. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis 18:2029-2033.
25. Peters, J. M., N. Hennuyer, B. Staels, J. Fruchart, C. Fievet, F. Gonzalez, and J. Auwerx. 1997. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor α-deficient mice. J. Biol. Chem. 272:27307-27312.
26. Read, T., C. Grunfeld, Z. Kumwenda, M. Calhoun, J. Kane, K. Feingold, and J. Rapp. 1995. Triglyceride-rich lipoproteins prevent septic death in rats. J. Exp. Med. 182:267-272.
27. Reed, L. J., and H. A. Muench. 1938. A simple method for estimating 50% end points. Am. J. Hyg. 27:493-499.
28. Ricote, M., A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass. 1998. The peroxisome proliferator-activated receptor gamma is a negative regulator of macrophage activation. Nature 391:79-82.
29. Robinson, C. E., X. Wu, D. C. Morris, and J. M. Gimble. 1998. DNA bending is induced by binding of the peroxisome proliferator-activated receptor gamma2 heterodimer to its response element in the murine lipoprotein lipase promoter. Biochem. Biophys. Res. Commun. 244:671-677.
30. Rose, M. L., D. R. Germolec, R. Schoonhoven, and R. G. Thurman. 1997. Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators. Carcinogenesis 18:1453-1456.
31. Rusyn, I., H. Tsukamoto, and R. G. Thurman. 1998. Wy-14 643 rapidly activates nuclear factor kappaB in Kupffer cells before hepatocytes. Carcinogenesis 19:1217-1222.
32. Schoonjans, K., B. Staels, and J. Auwerx. 1996. The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta 1302:93-109.
33. Schoonjans, K., J. Peinado-Onsurbe, R. Heyman, M. Briggs, D. Caayet, S. Deeb, B. Staels, and J. Auwerx. 1996. PPAR alpha and PPAR gamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 15:5336-5348.
34. Staels, B., A. V. Tol, J.-C. Fruchart, and J. Auwerx. 1996. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat. Isr. J. Med. Sci. 32:490-498.
35. Steineger, H., H. Sorensen, J. Tugwood, S. Skrede, O. Spydevold, and K. Gautvik. 1994. Dexamethasone and insulin demonstrate marked and opposite regulation of the steady-state mRNA level of the peroxisomal proliferator-activated receptor (PPAR) in hepatic cells. Eur. J. Biochem. 225:967-974.
36. Tontonoz, P., E. Hu, J. Devine, E. G. Beale, and B. M. Spiegelman. 1995. PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. Cell. Biol. 15:351-357.
37. Tracey, K., B. Beutler, S. Lowry, J. Merry-weather, S. Wolpe, I. Milsark, R. Hariri, T. Fahey III, A. Zentella, J. Albert, T. Shires, and A. Cerami. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.
38. Whelan, J. 1996. Antagonistic effects of dietary arachidonic acid and n-3 polyunsaturated fatty acids. J. Nutr. 126:10868-10915.
39. Yu, K., W. Bayona, C. B. Kallen, H. P. Harding, C. P. Ravera, G. McMahon, M. Brown, and M. A. Lazar. 1995. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270:23975-23983.
40. Zhang, B., L. L. Marcus, F. G. Sajadi, K. Alvares, J. K. Reddy, S. Subramani, R. A. Rachubinski, and J. P. Capone. 1992. Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc. Natl. Acad. Sci. USA 89:7541-7545.